Welcure Drugs & Pharmaceuticals Ltd — Important, 02-09-2025: Company Update

Welcure Drugs & Pharmaceuticals' Board has approved the appointment of M/s. Vishakha Agrawal & Associates as the Secretarial Auditor for a five-year term, starting from financial year 2025-26 until 2029-2030. This appointment, pending shareholder approval at the upcoming Annual General Meeting, aims to strengthen the company's compliance framework. The new auditor, led by an experienced Practicing Company Secretary, will provide essential oversight on company and securities law matters, enhancing governance for stakeholders.